Chyron Corp. (CGS) Share Price

Ya that is even pre-Button and pre-removing 5M shares with insider buying.

All anyone needs to know is that they have been shorting the stock in order to drive the PPS down. Why else has the stock symbol been reported as "Failures to Deliver"????

And then they clean that up and short the stock down again with more synthetic shares via "Dark Pool" trading. Ju

I’m visiting in Tampa and want to visit the site… maybe you have the address so I can pass by there?

$WYTC Uplisting to NASDAQ-
style="caret-color: rgb(0, 0, 0); color: rgba(0, 0, 0, 1); font-family: UICTFontTextStyleBody; font-size: 17px"Wytec’s near-term plans to uplist to NASDAQ represent a major milestone and investment catalyst. Historically, few OTC companies successfully make the tra

KRTL cant help some people, lol just hope they went to someone long and strong and not getting put back up for awhile

Dems have lost big, and have no power to stop Trump. 

$ILLR $1.025 +6.22% Triller moving back up today!

$HMBL

https://x.com/HUMBLPay/status/1894767238810611934?t=krmfahM-d7oPLMHzUp2rmw&s=19

King,
Would u consider guesstimate game :
if elite sold in next 3 months while on otc market price will be?
58 cents with caveat:
This is best we could do.

I'm right here bro..I'll take the criticism... When its constructive...not a personal attack..If I'm a fool for making money...so be it.🤑🤑🤑🤑

I agree that buying IFUS shares now and holding as IFUS builds revenues locally,nationally,and internationally with the potential Joint Venture in India expected to being finalized by Mid March.

The fruits of hard work and sales with India started when they visited the plant in Decem

CME
CME Group sets new daily volume record of 67.1M contracts
CME Group reported it reached a new, single-day volume record of 67,124,571 contracts traded on February 25. This surpasses the previous record of 66,256,756 contracts set on March 13, 2023. The company also hit new daily

CNNE
Cannae Holdings price target lowered to $23 from $27 at RBC Capital
RBC Capital analyst Kenneth Lee lowered the firm's price target on Cannae Holdings to $23 from $27 but keeps an Outperform rating on the shares after its Q4 results. The company continues to focus on re-balanci

666 wall now? Bueller? BUELLER?

thanks newman

~playin NVDA through the Qs bought 2/28 $540 calls @.06c 

Dealing 3s now! What a POS!

Bounce baby bounce…

$ADHC The Breakthrough Devices Program is intended to provide patients and health care providers with timely access to medical devices by speeding up development, assessment, and review for premarket approval, 510(k) clearance, and De Novo marketing authorization. Breakthrough Devices must meet the

$ONAR .055 +5.77% This strategic acquisition will double ONAR Subsidiary Storia's revenue and aligns with ONAR's mission to expand its network by operating best-in-class, tech-enabled businesses that service middle-market companies. https://finance.yahoo.com/news/onar-announces-signing-letter-intent

I'm in dino's camp, plan to wait at least until lst quarter FY 2026 financials are published and possibly beyond, unless it goes to $200 sooner🙂

$ONAR This strategic acquisition will double ONAR Subsidiary Storia's revenue and aligns with ONAR's mission to expand its network by operating best-in-class, tech-enabled businesses that service middle-market companies. https://finance.yahoo.com/news/onar-announces-signing-letter-intent-133000491.h

You're welcome. I can tell you dig deep into your work! It's very much appreciated. I'm saying that from a guy who doesn't speak Arabic but my mom was full-blooded Lebanese, the other half of me is mostly German. Even the way you present your graphics on X is great! Just one tiny, incidental spell

IMMUNO INVESTORS NOTEBOOK: $ESLA @ $1.10s: Given $16 one year target last week by highly regarded bio/pharma ETF....$ESLA a repeat of Immuno $IOVA & $SMMT monster moves. Clinical Trial update due. Last one was truly eye opening.
Link: 9/29/24
https://finance.yahoo.com/news/estrella-im

Everyone? No one is here lol. No one cares.